Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cellebrite DISTU:9W9 -0.88%67 PS Ratio is 7.95 as of Aug. 06, 2026, which is 21% above its 10-year median of 6.57. GuruFocus rates STU:9W9 with a GF Score™ of 67/100 and a GF Value™ of €13.79 (Fairly Valued). The stock has 3 warning signs investors should review. Among 2,785 Software companies, Cellebrite DI ranks worse than 83.48% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cellebrite DI's share price is €13.53.
Cellebrite DI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €1.70. Hence, Cellebrite DI's PS Ratio for today is 7.95.
The historical rank and industry rank for Cellebrite DI's PS Ratio or its related term are showing as below:
STU:9W9'
s PS Ratio Range Over the Past 10 Years
Min: 2.9 Med: 6.57 Max: 13.27
Current: 7.62
During the past 7 years, Cellebrite DI's highest PS Ratio was 13.27. The lowest was 2.90. And the median was 6.57.
STU:9W9's PS Ratio is ranked worse than 83.48% of 2785
companies
in the Software industry
Industry Median: 2.04
vs STU:9W9: 7.62
Cellebrite DI Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Cellebrite DI was 4.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year.
During the past 7 years, Cellebrite DI's highest 3-Year average Revenue per Share Growth Rate was 18.00% per year. The lowest was 7.90% per year. And the median was 12.95% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cellebrite DI PS Ratio Related Terms
Cellebrite DI PS Ratio Historical Data
* Premium members only.
The historical data trend for Cellebrite DI's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Infrastructure subindustry, Cellebrite DI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellebrite DI PS Ratio vs Software Industry
For the Software industry and Technology sector, Cellebrite DI's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cellebrite DI's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cellebrite DI's Share Price of today is €13.53. Cellebrite DI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.70.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Cellebrite DI (STU:9W9) has a PS Ratio of 7.95 as of Aug. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cellebrite DI and its competitors. This is 21% above median its historical median of 6.57. Over the past decade, Cellebrite DI's PS Ratio has ranged from 2.90 to 13.27. According to the industry distribution chart, Cellebrite DI ranks #2325 out of 2785 companies in the Software industry, placing it in the top 83.5%.
Is Cellebrite DI's PS Ratio too high?
Cellebrite DI's current PS Ratio of 7.95 is 21% above median its 10-year median of 6.57. Over the past 10 years, this metric has ranged from a low of 2.90 to a high of 13.27. The Software industry median PS Ratio is 2.04. Cellebrite DI's value of 7.95 is 289.7% above this industry median. Based on the distribution chart, Cellebrite DI ranks #2325 out of 2785 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Cellebrite DI has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's PS Ratio compare to TENB and PAY?
According to the Software industry distribution chart, Cellebrite DI ranks #2325 out of 2785 companies for PS Ratio. This places Cellebrite DI in the lower half of its industry. The industry median PS Ratio is 2.04. Cellebrite DI's value of 7.95 is 289.7% above this benchmark. Historically, Cellebrite DI's own PS Ratio has ranged from 2.90 to 13.27 over the past decade. While the company's 10-year median is 6.57 vs. the industry median of 2.04, Cellebrite DI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Software company?
The median PS Ratio among Software companies is 2.04, based on 2,785 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cellebrite DI's current PS Ratio of 7.95 is 289.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cellebrite DI and its competitors. For the Software industry, the median PS Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellebrite DI's current PS Ratio is 7.95, which is 21% above median its own 10-year median of 6.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Based on GuruFocus' analysis, Cellebrite DI (STU:9W9) is currently considered Fairly Valued. The stock's GF Value™ is €13.79, compared to a current price of €13.53 — trading 1.9% below its estimated fair value. The current PS Ratio is 7.95, which is 21% above median its 10-year median of 6.57 and 289.7% above the Software industry median of 2.04. Cellebrite DI's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Cellebrite DI (STU:9W9), the current PS Ratio is 7.95 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cellebrite DI (STU:9W9) Overvalued in 2026?
Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued.
The current stock price of €13.53 is trading 1.9% below its estimated GF Value™ of €13.79.
GuruFocus considers Cellebrite DI to be Fairly Valued.
Key valuation signals for STU:9W9:
PS Ratio: 7.95 (21% above median its 10-year median of 6.57)
GF Value™: €13.79 vs. price of €13.53 (1.9% below fair value)
Industry Position: 289.7% above the Software median (#2325 of 2785)
No single metric tells the full story. See the STU:9W9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
67GF Score
Get the complete analysis for STU:9W9
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:9W9 has been successfully added to your 
